MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2022.944013

Медицинская библиотека · Frontiers in immunology · 2022

Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib.

Xing Qian, Zhang Zhongwei, Zhu Biao, Lin Qionghua, Shen Lihua, Li Fangfang, Xia Zhili, Zhao Zhiyong

Клинический случайСтатьяПеревод в очереди

Аннотация

INTRODUCTION

Immune therapy has ushered in a new era of tumor treatment, at the expense of immune-related adverse events, including rare but fatal adverse cardiovascular events, such as myocarditis. Steroids remain the cornerstone of therapy for immune-related myocarditis, with no clear consensus on additional immunosuppressive treatment for steroid-refractory cases yet.

CASE REPORT: Here, we report a patient with stage IV nasopharyngeal carcinoma who developed immune-related myocarditis in the fourth course of therapy with immune checkpoint inhibitors. The patient presented with precordial discomfort with elevation of cardiac enzymes and interleukin-6, atypical electrocardiographic abnormalities, and reduced left ventricular ejection fraction. Coronary computed tomography angiography excluded the possibility of acute coronary syndrome. The therapy with tofacitinib targeting the Janus kinase-signal transducer and activator of transcription signal pathway was successfully conducted, since there was no significant improvement in troponin under high-dose steroid and intravenous immunoglobulin treatment. The patient recovered without major adverse cardiac events during hospitalization.

DISCUSSION: The safety and efficacy of tofacitinib in a patient with steroid-refractory immune-related myocarditis were investigated, hoping to provide a basis for prospective therapeutic strategies. Tofacitinib led to remarkable remissions in primary autoimmune disease by blocking the inflammatory cascade, indicating its potential therapeutic use in immune-related adverse events.

Для цитирования: Xing Qian, Zhang Zhongwei, Zhu Biao, Lin Qionghua, Shen Lihua, Li Fangfang, Xia Zhili, Zhao Zhiyong. Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib.. Frontiers in immunology. 2022. DOI: 10.3389/fimmu.2022.944013.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.